Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 149 articles:
HTML format
Text format



Single Articles


    July 2019
  1. GUO F, Chen C, Schottker B, Holleczek B, et al
    Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
    Int J Cancer. 2019 Jul 10. doi: 10.1002/ijc.32566.
    PubMed     Text format     Abstract available


  2. KARIV R, Caspi M, Fliss-Isakov N, Shorer Y, et al
    Resorting the function of the colorectal cancer (CRC) gate keeper adenomatous Polyposis Coli (APC).
    Int J Cancer. 2019 Jul 8. doi: 10.1002/ijc.32557.
    PubMed     Text format     Abstract available


  3. HE Y, Theodoratou E, Li X, Din FV, et al
    Effects of common genetic variants associated with colorectal cancer risk on survival outcomes after diagnosis: a large population-based cohort study.
    Int J Cancer. 2019 Jul 4. doi: 10.1002/ijc.32550.
    PubMed     Text format     Abstract available


    June 2019

  4. Erratum: Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register-based study.
    Int J Cancer. 2019;144:E9-E11.
    PubMed     Text format    


  5. BESHARA A, Ahoroni M, Comanester D, Vilkin A, et al
    Association Between Time to Colonoscopy After a Positive Guaiac Fecal Test Result and Risk of Colorectal Cancer and Advanced Stage Disease at Diagnosis.
    Int J Cancer. 2019 Jun 7. doi: 10.1002/ijc.32497.
    PubMed     Text format     Abstract available


  6. GUO TA, Wu YC, Tan C, Jin YT, et al
    Clinicopathologic features and prognostic value of KRAS, NRAS, and BRAF mutations and DNA mismatch repair status: a single-center retrospective study of 1834 Chinese patients with stage I-IV colorectal cancer.
    Int J Cancer. 2019 Jun 4. doi: 10.1002/ijc.32489.
    PubMed     Text format     Abstract available


    May 2019
  7. MORI N, Sawada N, Iwasaki M, Yamaji T, et al
    Circulating sex hormone levels and colorectal cancer risk in Japanese postmenopausal women: The JPHC nested case-control study.
    Int J Cancer. 2019 May 27. doi: 10.1002/ijc.32431.
    PubMed     Text format     Abstract available


  8. CHEN Y, Liu Z, Wang H, Tang Z, et al
    VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer.
    Int J Cancer. 2019 May 24. doi: 10.1002/ijc.32429.
    PubMed     Text format     Abstract available


  9. HE X, Wu K, Zhang X, Nishihara R, et al
    Dietary intake of fiber, whole grains and risk of colorectal cancer: an updated analysis according to food sources, tumor location and molecular subtypes in two large US cohorts.
    Int J Cancer. 2019 May 1. doi: 10.1002/ijc.32382.
    PubMed     Text format     Abstract available


    April 2019
  10. MCNABB S, Harrison TA, Albanes D, Berndt SI, et al
    Meta-analysis of 16 studies of the association of alcohol with colorectal cancer.
    Int J Cancer. 2019 Apr 29. doi: 10.1002/ijc.32377.
    PubMed     Text format     Abstract available


  11. KHAN N, Jajeh F, Eberhardt EL, Miller DD, et al
    Fisetin and 5-Fluorouracil: Effective Combination for PIK3CA-Mutant Colorectal Cancer.
    Int J Cancer. 2019 Apr 24. doi: 10.1002/ijc.32367.
    PubMed     Text format     Abstract available


  12. DE KORT S, Simons CCJM, van den Brandt PA, Janssen-Heijnen MLG, et al
    Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk.
    Int J Cancer. 2019 Apr 24. doi: 10.1002/ijc.32365.
    PubMed     Text format     Abstract available


  13. CHERNYAVSKIY P, Kennerley VM, Jemal A, Little MP, et al
    Heterogeneity of colon and rectum cancer incidence across 612 SEER counties, 2000-2014.
    Int J Cancer. 2019;144:1786-1795.
    PubMed     Text format     Abstract available


  14. CHENG WC, Liao TT, Lin CC, Yuan LE, et al
    RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer.
    Int J Cancer. 2019 Apr 13. doi: 10.1002/ijc.32338.
    PubMed     Text format     Abstract available


  15. MINI E, Lapucci A, Perrone G, D'Aurizio R, et al
    RNA sequencing reveals PNN and KCNQ1OT1as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
    Int J Cancer. 2019 Apr 11. doi: 10.1002/ijc.32326.
    PubMed     Text format     Abstract available


  16. OSUMI H, Shinozaki E, Wakatsuki T, Suenaga M, et al
    Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.
    Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32320.
    PubMed     Text format     Abstract available


  17. ZUR HAUSEN H, Bund T, de Villiers EM
    Specific nutritional infections early in life as risk factors for human colon and breast cancers several decades later.
    Int J Cancer. 2019;144:1574-1583.
    PubMed     Text format    


  18. FIEDLER D, Heselmeyer-Haddad K, Hirsch D, Hernandez LS, et al
    Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence.
    Int J Cancer. 2019;144:1561-1573.
    PubMed     Text format     Abstract available


  19. PEREA J, Garcia JL, Corchete L, Lumbreras E, et al
    Redefining synchronous colorectal cancers based on tumor clonality.
    Int J Cancer. 2019;144:1596-1608.
    PubMed     Text format     Abstract available


    March 2019
  20. UNGARO F, Colombo P, Massimino L, Ugolini GS, et al
    Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11.
    Int J Cancer. 2019 Mar 19. doi: 10.1002/ijc.32286.
    PubMed     Text format     Abstract available


  21. SUGIYAMA H, Misumi M, Brenner A, Grant EJ, et al
    Radiation risk of incident colorectal cancer by anatomical site among atomic bomb survivors: 1958-2009.
    Int J Cancer. 2019 Mar 15. doi: 10.1002/ijc.32275.
    PubMed     Text format     Abstract available


  22. DIZDAR L, Werner TA, Drusenheimer JC, Mohlendick B, et al
    BRAF(V600E) mutation: A promising target in colorectal neuroendocrine carcinoma.
    Int J Cancer. 2019;144:1379-1390.
    PubMed     Text format     Abstract available


  23. BALAVARCA Y, Weigl K, Thomsen H, Brenner H, et al
    Performance of individual and joint risk stratification by an environmental risk score and a genetic risk score in a colorectal cancer screening setting.
    Int J Cancer. 2019 Mar 14. doi: 10.1002/ijc.32272.
    PubMed     Text format     Abstract available


  24. EL KINANY K, Huybrechts I, Kampman E, Boudouaya HA, et al
    Concordance with the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention and colorectal cancer risk in Morocco: A large, population-based case-control study.
    Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32263.
    PubMed     Text format     Abstract available


  25. XIN J, Du M, Gu D, Ge Y, et al
    Combinations of Single Nucleotide Polymorphisms Identified in Genome-wide Association Studies Determine Risk for Colorectal Cancer.
    Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32267.
    PubMed     Text format     Abstract available


  26. TOKUNAGA R, Cao S, Naseem M, Battaglin F, et al
    AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: a meta-analysis using TRIBE, MAVERICC, and FIRE3.
    Int J Cancer. 2019 Mar 11. doi: 10.1002/ijc.32261.
    PubMed     Text format     Abstract available


  27. LI S, Shi X, Chen M, Xu N, et al
    Angiogenin promotes colorectal cancer metastasis via tiRNA production.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32245.
    PubMed     Text format     Abstract available


  28. NANDA N, Mahmood S, Bhatia A, Mahmood A, et al
    Chemopreventive role of olive oil in colon carcinogenesis by targeting noncoding RNAs and methylation machinery.
    Int J Cancer. 2019;144:1180-1194.
    PubMed     Text format     Abstract available


    February 2019
  29. SUN B, Zhou Y, Fang Y, Li Z, et al
    Colorectal cancer exosomes induce lymphatic network remodeling in lymph nodes.
    Int J Cancer. 2019 Feb 8. doi: 10.1002/ijc.32196.
    PubMed     Text format     Abstract available


  30. ALNABULSI A, Cash B, Hu Y, Silina L, et al
    The expression of brown fat associated proteins in colorectal cancer and the relationship of uncoupling protein 1 with prognosis.
    Int J Cancer. 2019 Feb 8. doi: 10.1002/ijc.32198.
    PubMed     Text format     Abstract available


  31. BARRY EL, Lund JL, Westreich D, Mott LA, et al
    Body mass index, calcium supplementation and risk of colorectal adenomas.
    Int J Cancer. 2019;144:448-458.
    PubMed     Text format     Abstract available


    January 2019
  32. ANTELO M, Golubicki M, Roca E, Mendez G, et al
    Lynch-like syndrome is as frequent as Lynch syndrome in early-onset non-familial non-polyposis colorectal cancer.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32160.
    PubMed     Text format     Abstract available


  33. GEIJSEN AJMR, Brezina S, Keski-Rahkonen P, Baierl A, et al
    Plasma metabolites associated with colorectal cancer: A discovery-replication strategy.
    Int J Cancer. 2019 Jan 21. doi: 10.1002/ijc.32146.
    PubMed     Text format     Abstract available


  34. CHENG X, Jin Z, Ji X, Shen X, et al
    ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
    Int J Cancer. 2019 Jan 16. doi: 10.1002/ijc.32071.
    PubMed     Text format     Abstract available


  35. SOW HS, Benonisson H, Breukel C, Visser R, et al
    FcgammaR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model.
    Int J Cancer. 2019;144:345-354.
    PubMed     Text format     Abstract available


  36. HOFFMEISTER M, Holleczek B, Stock C, Zwink N, et al
    Utilization and determinants of follow-up colonoscopies within 6 years after screening colonoscopy: Prospective cohort study.
    Int J Cancer. 2019;144:402-410.
    PubMed     Text format     Abstract available


  37. DEVAUD C, Tilkin-Mariame AF, Vignolle-Vidoni A, Souleres P, et al
    FAK alternative splice mRNA variants expression pattern in colorectal cancer.
    Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32120.
    PubMed     Text format     Abstract available


  38. WONG R, Tie J, Lee M, Cohen J, et al
    The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with non-specific findings on standard investigations.
    Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32117.
    PubMed     Text format     Abstract available


  39. YAN C, Huang WY, Boudreau J, Mayavannan A, et al
    IL-17R deletion predicts high-grade colorectal cancer and poor clinical outcomes.
    Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32122.
    PubMed     Text format     Abstract available


  40. SONG M, Ou FS, Zemla TJ, Hull MA, et al
    Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance).
    Int J Cancer. 2019 Jan 8. doi: 10.1002/ijc.32113.
    PubMed     Text format     Abstract available


  41. JORISSEN RN, Croxford M, Jones IT, Ward RL, et al
    Evaluation of the Transferability of Survival Calculators for Stage II/III Colon Cancer Across Healthcare Systems.
    Int J Cancer. 2019 Jan 8. doi: 10.1002/ijc.32100.
    PubMed     Text format     Abstract available


  42. MODEST DP, Rivera F, Bachet JB, de Braud F, et al
    Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: a retrospective analysis of two randomised trials.
    Int J Cancer. 2019 Jan 7. doi: 10.1002/ijc.32110.
    PubMed     Text format     Abstract available


  43. MYTE R, Gylling B, Haggstrom J, Haggstrom C, et al
    Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status.
    Int J Cancer. 2019 Jan 7. doi: 10.1002/ijc.32104.
    PubMed     Text format     Abstract available


  44. HU J, Shan Y, Ma J, Pan Y, et al
    LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating alpha-2, 3 sialylation via PI3K/Akt signaling.
    Int J Cancer. 2019 Jan 7. doi: 10.1002/ijc.32103.
    PubMed     Text format     Abstract available


    December 2018
  45. WARD HA, Murphy N, Weiderpass E, Leitzmann MF, et al
    Gallstones and incident colorectal cancer in a large pan-European cohort study.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32090.
    PubMed     Text format     Abstract available


  46. VICENTINI M, Zorzi M, Bovo E, Mancuso P, et al
    Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer. Results from the IMPATTO study.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32089.
    PubMed     Text format     Abstract available


  47. REN A, Sun S, Li S, Chen T, et al
    Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer.
    Int J Cancer. 2018 Dec 18. doi: 10.1002/ijc.32079.
    PubMed     Text format     Abstract available


  48. ZAIMENKO I, Jaeger C, Brenner H, Chang-Claude J, et al
    Non-invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: the DACHS study.
    Int J Cancer. 2018 Dec 18. doi: 10.1002/ijc.32076.
    PubMed     Text format     Abstract available


  49. HAMERS FF, Assogba FAG, Rogel A
    Implementation and organization of cancer screening in France.
    Int J Cancer. 2018;143:3281.
    PubMed     Text format    


  50. YANG T, Li X, Montazeri Z, Little J, et al
    Gene-environment interactions and colorectal cancer risk: an umbrella review of systematic reviews and meta-analyses of observational studies.
    Int J Cancer. 2018 Dec 11. doi: 10.1002/ijc.32057.
    PubMed     Text format     Abstract available


  51. ARAGHI M, Soerjomataram I, Jenkins M, Brierley J, et al
    Global trends in colorectal cancer mortality: projections to the year 2035.
    Int J Cancer. 2018 Dec 10. doi: 10.1002/ijc.32055.
    PubMed     Text format     Abstract available


  52. ROSEWEIR AK, Clark J, McSorley ST, van Wyk HC, et al
    The association between markers of tumor cell metabolism, the tumor microenvironment and outcomes in patients with colorectal cancer.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32045.
    PubMed     Text format     Abstract available


  53. PETIMAR J, Tabung FK, Valeri L, Rosner B, et al
    Mediation of Associations Between Adiposity and Colorectal Cancer Risk by Inflammatory and Metabolic Biomarkers.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32047.
    PubMed     Text format     Abstract available


  54. JIANG W, Cai M, Li S, Bei J, et al
    Universal screening for Lynch Syndrome in a large consecutive cohort of Chinese colorectal cancer patients: high prevalence and unique molecular features.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32044.
    PubMed     Text format     Abstract available


  55. IBRAHIM A, Hugerth L, Hases L, Saxena A, et al
    Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
    Int J Cancer. 2018 Dec 4. doi: 10.1002/ijc.32037.
    PubMed     Text format     Abstract available


  56. GRAF ME, Sookthai D, Johnson T, Schubel R, et al
    Pre-diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP-selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study.
    Int J Cancer. 2018;143:2659-2667.
    PubMed     Text format     Abstract available


  57. KAYSER K, Degenhardt F, Holzapfel S, Horpaopan S, et al
    Copy number variation analysis and targeted NGS in 77 families with suspected Lynch syndrome reveals novel potential causative genes.
    Int J Cancer. 2018;143:2800-2813.
    PubMed     Text format     Abstract available


    November 2018
  58. DAI Z, Zhang J, Wu Q, Chen J, et al
    The role of microbiota in the development of colorectal cancer.
    Int J Cancer. 2018 Nov 26. doi: 10.1002/ijc.32017.
    PubMed     Text format     Abstract available


  59. EIDE PW, Eilertsen IA, Sveen A, Lothe RA, et al
    Long non-coding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties.
    Int J Cancer. 2018 Nov 17. doi: 10.1002/ijc.31998.
    PubMed     Text format     Abstract available


  60. ZHU L, Yan F, Wang Z, Dong H, et al
    Genome-wide DNA methylation profiling of primary colorectal laterally spreading tumors identifies disease-specific epimutations on common pathways.
    Int J Cancer. 2018;143:2488-2498.
    PubMed     Text format     Abstract available


  61. WANG G, Wang Q, Huang Q, Chen Y, et al
    Upregulation of mtSSB by interleukin-6 promotes cell growth through mitochondrial biogenesis-mediated telomerase activation in colorectal cancer.
    Int J Cancer. 2018 Nov 10. doi: 10.1002/ijc.31978.
    PubMed     Text format     Abstract available


  62. FU X, Huang Y, Fan X, Deng Y, et al
    Demographic Trends and KRAS/BRAF(V600E) Mutations in Colorectal Cancer Patients of South China: a Single-site Report.
    Int J Cancer. 2018 Nov 10. doi: 10.1002/ijc.31973.
    PubMed     Text format     Abstract available


  63. AMITAY EL, Cuk K, Niedermaier T, Weigl K, et al
    Factors Associated with False Positive Fecal Immunochemical Tests in a Large German Colorectal Cancer Screening Study.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31972.
    PubMed     Text format     Abstract available


  64. SUENAGA M, Cao S, Zhang W, Yang D, et al
    Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31968.
    PubMed     Text format     Abstract available


  65. ETEMADI A, Abnet CC, Graubard BI, Beane-Freeman L, et al
    Anatomical subsite can modify the association between meat and meat compounds and risk of colorectal adenocarcinoma: Findings from three large US cohorts.
    Int J Cancer. 2018;143:2261-2270.
    PubMed     Text format     Abstract available


    October 2018
  66. FUJI T, Umeda Y, Nyuya A, Taniguchi F, et al
    Detection of Circulating MicroRNAs with Ago2 Complexes to Monitor the Tumor Dynamics of Colorectal Cancer Patients during Chemotherapy.
    Int J Cancer. 2018 Oct 31. doi: 10.1002/ijc.31960.
    PubMed     Text format     Abstract available


  67. YANG Y, Cai Q, Shu XO, Steinwandel MD, et al
    Prospective Study of Oral Microbiome and Colorectal Cancer Risk in Low-income and African American Populations.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31941.
    PubMed     Text format     Abstract available


  68. ABDUL-WAHID A, Cydzik M, Fischer NW, Prodeus A, et al
    Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells.
    Int J Cancer. 2018;143:1963-1977.
    PubMed     Text format     Abstract available


  69. VACCARO CA, Lopez-Kostner F, Valle AD, Palmero EI, et al
    From colorectal cancer pattern to the characterization of individuals at risk: picture for genetic research in Latin America.
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31920.
    PubMed     Text format     Abstract available


  70. RATJEN I, Shivappa N, Schafmayer C, Burmeister G, et al
    Association between the dietary inflammatory index and all-cause mortality in colorectal cancer long-term survivors.
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31919.
    PubMed     Text format     Abstract available


    September 2018
  71. BORMANN F, Stinzing S, Tierling S, Morkel M, et al
    Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer.
    Int J Cancer. 2018 Sep 25. doi: 10.1002/ijc.31892.
    PubMed     Text format     Abstract available


  72. GARGALLO CJ, Lanas A, Carrera-Lasfuentes P, Ferrandez A, et al
    Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer.
    Int J Cancer. 2018 Sep 8. doi: 10.1002/ijc.31858.
    PubMed     Text format     Abstract available


  73. KLEIN CH, Truxius DC, Vogel HA, Harizanova J, et al
    PDEdelta inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas.
    Int J Cancer. 2018 Sep 8. doi: 10.1002/ijc.31859.
    PubMed     Text format     Abstract available


    August 2018
  74. PRASETYANTI PR, van Hooff SR, van Herwaarden T, de Vries N, et al
    Capturing Colorectal Cancer Inter-Tumor Heterogeneity in Patient-Derived Xenograft (PDX) Models.
    Int J Cancer. 2018 Aug 27. doi: 10.1002/ijc.31767.
    PubMed     Text format     Abstract available


  75. SONG M, Sasazuki S, Camargo MC, Shimazu T, et al
    Circulating Inflammatory Markers and Colorectal Cancer Risk: A Prospective Case-cohort Study in Japan.
    Int J Cancer. 2018 Aug 21. doi: 10.1002/ijc.31821.
    PubMed     Text format     Abstract available


  76. EILERTSEN IA, Sveen A, Stromme JM, Skotheim RI, et al
    Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer.
    Int J Cancer. 2018 Aug 19. doi: 10.1002/ijc.31809.
    PubMed     Text format     Abstract available


  77. KIVES Z, Juhasz K, Csakvari T, Agoston I, et al
    Cancer screening policy in Hungary.
    Int J Cancer. 2018;143:1003-1004.
    PubMed     Text format    


  78. RADA-FERNANDEZ DE JAUREGUI D, Evans CEL, Jones P, Greenwood DC, et al
    Common dietary patterns and risk of cancers of the colon and rectum: Analysis from the United Kingdom Women's Cohort Study (UKWCS).
    Int J Cancer. 2018;143:773-781.
    PubMed     Text format     Abstract available


  79. BROUWER NPM, Bos ACRK, Lemmens VEPP, Tanis PJ, et al
    An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients.
    Int J Cancer. 2018 Aug 10. doi: 10.1002/ijc.31785.
    PubMed     Text format     Abstract available


  80. CAI M, Zhang H, Hou L, Gao W, et al
    Inhibiting homologous recombination decreases extrachromosomal amplification but has no effect on intrachromosomal amplification in methotrexate-resistant colon cancer cells.
    Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31781.
    PubMed     Text format     Abstract available


  81. KWOK ZH, Roche V, Chew XH, Fadieieva A, et al
    A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers.
    Int J Cancer. 2018;143:668-678.
    PubMed     Text format     Abstract available


    July 2018
  82. ROSEWEIR AK, Kong CY, Park JH, Bennett L, et al
    A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with stage II/III colorectal cancer.
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31739.
    PubMed     Text format     Abstract available


  83. YUAN Y, Qi G, Shen H, Guo A, et al
    Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer.
    Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31736.
    PubMed     Text format     Abstract available


  84. CHEN C, Stock C, Hoffmeister M, Brenner H, et al
    How long does it take until the effects of endoscopic screening on colorectal cancer mortality are fully disclosed? : A Markov model study.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31716.
    PubMed     Text format     Abstract available


  85. PARK YL, Kim HP, Cho YW, Min DW, et al
    Activation of WNT/beta-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31662.
    PubMed     Text format     Abstract available


  86. PAPANTONIOU K, Devore EE, Massa J, Strohmaier S, et al
    Rotating Night Shift work and Colorectal Cancer Risk in the Nurses' Health Studies.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31655.
    PubMed     Text format     Abstract available


  87. AHADOVA A, Gallon R, Gebert J, Ballhausen A, et al
    Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
    Int J Cancer. 2018;143:139-150.
    PubMed     Text format     Abstract available


    June 2018
  88. BOYSEN AK, Spindler KL, Hoyer M, Mortensen FV, et al
    Metastasis directed therapy for liver and lung metastases from colorectal cancer - a population based study.
    Int J Cancer. 2018 Jun 19. doi: 10.1002/ijc.31626.
    PubMed     Text format     Abstract available


  89. DASHTI SG, Win AK, Hardikar SS, Glombicki SE, et al
    Physical activity and the risk of colorectal cancer in Lynch syndrome.
    Int J Cancer. 2018 Jun 14. doi: 10.1002/ijc.31611.
    PubMed     Text format     Abstract available


  90. MAO Y, Feng Q, Zheng P, Yang L, et al
    Low Tumor Infiltrating Mast Cell Density Confers Prognostic Benefit and Reflects Immunoactivation in Colorectal Cancer.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31613.
    PubMed     Text format     Abstract available


  91. FORMICA V, Zaniboni A, Loupakis F, Roselli M, et al
    Non-inferiority of three months vs six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31616.
    PubMed     Text format     Abstract available


    May 2018
  92. GYLLING B, Myte R, Ulvik A, Ueland PM, et al
    One-carbon metabolite ratios as functional B-vitamin markers and in relation to colorectal cancer risk.
    Int J Cancer. 2018 May 22. doi: 10.1002/ijc.31606.
    PubMed     Text format     Abstract available


  93. HUANG X, Yang Y, Zhao Y, Cao D, et al
    RhoA-stimulated intra-capillary morphology switch facilitates the arrest of individual circulating tumor cells.
    Int J Cancer. 2018;142:2094-2105.
    PubMed     Text format     Abstract available


  94. TAYLOR ES, McCall JL, Shen S, Girardin A, et al
    Prognostic roles for IL-2-producing and CD69(+) T cell subsets in colorectal cancer patients.
    Int J Cancer. 2018 May 11. doi: 10.1002/ijc.31598.
    PubMed     Text format     Abstract available


    April 2018
  95. MURPHY N, Achaintre D, Zamora-Ros R, Jenab M, et al
    A Prospective Evaluation of Plasma Polyphenol Levels and Colon Cancer Risk.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31563.
    PubMed     Text format     Abstract available


  96. CHEN L, Pan X, Hu X, Zhang YH, et al
    Gene expression differences among different MSI statuses in colorectal cancer.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31554.
    PubMed     Text format     Abstract available


  97. BARRUBES L, Babio N, Mena-Sanchez G, Toledo E, et al
    Dairy product consumption and risk of colorectal cancer in an older Mediterranean population at high cardiovascular risk.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31540.
    PubMed     Text format     Abstract available


  98. TRIFF K, McLean MW, Callaway E, Goldsby J, et al
    Dietary fat and fiber interact to uniquely modify global histone post-translational epigenetic programming in a rat colon cancer progression model.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31525.
    PubMed     Text format     Abstract available


  99. WU JC, Tsai ML, Lai CS, Lo CY, et al
    Polymethoxyflavones prevent benzo[a]pyrene/dextran sodium sulfate-induced colorectal carcinogenesis through modulating xenobiotic metabolism and ameliorate autophagic defect in ICR mice.
    Int J Cancer. 2018;142:1689-1701.
    PubMed     Text format     Abstract available


  100. LIU X, Zhou W, Zhang X, Ding Y, et al
    1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
    Int J Cancer. 2018 Apr 1. doi: 10.1002/ijc.31417.
    PubMed     Text format     Abstract available


  101. TABATABAEI M, Mosaffa N, Ghods R, Nikoo S, et al
    Vaccination with human amniotic epithelial cells confer effective protection in a murine model of Colon adenocarcinoma.
    Int J Cancer. 2018;142:1453-1466.
    PubMed     Text format     Abstract available


    March 2018
  102. LI X, Guo X, Li D, Du X, et al
    Multi-regional Sequencing Reveals Intratumor Heterogeneity and Positive Selection of Somatic mtDNA Mutations in Hepatocellular Carcinoma and Colorectal Cancer.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31395.
    PubMed     Text format     Abstract available


  103. FADDA A, Gentilini D, Moi L, Barault L, et al
    Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor.
    Int J Cancer. 2018 Mar 15. doi: 10.1002/ijc.31380.
    PubMed     Text format     Abstract available


  104. ZHOU M, Liu X, Li Z, Huang Q, et al
    Caspase-3 regulates the migration, invasion, and metastasis of colon cancer cells.
    Int J Cancer. 2018 Mar 10. doi: 10.1002/ijc.31374.
    PubMed     Text format     Abstract available


  105. PAN P, Oshima K, Huang YW, Agle KA, et al
    Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.
    Int J Cancer. 2018 Mar 9. doi: 10.1002/ijc.31366.
    PubMed     Text format     Abstract available


    February 2018
  106. MARQUEZ J, Fernandez-Pineiro I, Arauzo-Bravo MJ, Poschmann G, et al
    Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver.
    Int J Cancer. 2018 Feb 28. doi: 10.1002/ijc.31343.
    PubMed     Text format     Abstract available


  107. KABAT GC, Kim MY, Stefanick M, Ho GYF, et al
    Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women.
    Int J Cancer. 2018 Feb 27. doi: 10.1002/ijc.31345.
    PubMed     Text format     Abstract available


  108. SHU X, Xiang YB, Rothman N, Yu D, et al
    Prospective study of blood metabolites associated with colorectal cancer risk.
    Int J Cancer. 2018 Feb 26. doi: 10.1002/ijc.31341.
    PubMed     Text format     Abstract available


  109. WU S, Meng Q, Zhang C, Sun H, et al
    DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus.
    Int J Cancer. 2018 Feb 15. doi: 10.1002/ijc.31318.
    PubMed     Text format     Abstract available


  110. KASHINO I, Akter S, Mizoue T, Sawada N, et al
    Coffee drinking and colorectal cancer and its subsites: A pooled analysis of 8 cohort studies in Japan.
    Int J Cancer. 2018 Feb 15. doi: 10.1002/ijc.31320.
    PubMed     Text format     Abstract available


  111. KOREHISA S, Oki E, Iimori M, Nakaji Y, et al
    Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
    Int J Cancer. 2018;142:822-832.
    PubMed     Text format     Abstract available


  112. LEW JB, James D, St John B, Macrae FA, et al
    Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31314.
    PubMed     Text format     Abstract available


  113. AMSHOFF Y, Maskarinec G, Shvetsov YB, Raquinio PH, et al
    Type 2 Diabetes and Colorectal Cancer Survival: The Multiethnic Cohort.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31311.
    PubMed     Text format     Abstract available


  114. SCHULLEHNER J, Hansen B, Thygesen M, Pedersen CB, et al
    Nitrate in drinking water and colorectal cancer risk: A nationwide population-based cohort study.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31306.
    PubMed     Text format     Abstract available


  115. FRANSGAARD T, Thygesen LC, Gogenur I
    Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register-based study.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31305.
    PubMed     Text format     Abstract available


    January 2018
  116. O'BRIEN SJ, Carter JV, Burton JF, Oxford BG, et al
    The role of the miR-200 Family in Epithelial-Mesenchymal Transition in Colorectal Cancer: A Systematic Review.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31282.
    PubMed     Text format     Abstract available


  117. ISHIKAWA T, Okayama T, Sakamoto N, Ideno M, et al
    Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31285.
    PubMed     Text format     Abstract available


  118. BUTT J, Jenab M, Willhauck-Fleckenstein M, Michel A, et al
    Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer.
    Int J Cancer. 2018 Jan 29. doi: 10.1002/ijc.31283.
    PubMed     Text format     Abstract available


  119. MA H, Wu Z, Peng J, Li Y, et al
    Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab.
    Int J Cancer. 2018 Jan 24. doi: 10.1002/ijc.31274.
    PubMed     Text format     Abstract available


  120. SETTE G, Salvati V, Giordani I, Pillozzi E, et al
    Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.
    Int J Cancer. 2018 Jan 17. doi: 10.1002/ijc.31260.
    PubMed     Text format     Abstract available


  121. VAN SEBILLE YZA, Gibson RJ, Wardill HR, Ball IA, et al
    Dacomitinib-induced diarrhea: Targeting chloride secretion with crofelemer.
    Int J Cancer. 2018;142:369-380.
    PubMed     Text format     Abstract available


  122. BASU P, Ponti A, Anttila A, Ronco G, et al
    Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.
    Int J Cancer. 2018;142:44-56.
    PubMed     Text format     Abstract available


    December 2017
  123. GIES A, Bhardwaj M, Stock C, Schrotz-King P, et al
    Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31233.
    PubMed     Text format     Abstract available


  124. LIU W, Wang S, Sun Q, Yang Z, et al
    DCLK1 Promotes Epithelial-Mesenchymal Transition via the PI3K/Akt/NF-kappaB Pathway in Colorectal Cancer.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31232.
    PubMed     Text format     Abstract available


  125. JI J, Sundquist J, Sundquist K
    Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
    Int J Cancer. 2017 Dec 22. doi: 10.1002/ijc.31228.
    PubMed     Text format     Abstract available


  126. FENG HC, Lin JY, Hsu SH, Lan WY, et al
    Low folate metabolic stress reprograms DNA methylation-activated sonic hedgehog signaling to mediate cancer stem cell-like signatures and invasive tumour stage-specific malignancy of human colorectal cancers.
    Int J Cancer. 2017;141:2537-2550.
    PubMed     Text format     Abstract available


  127. ZHOU R, Shao Z, Liu J, Zhan W, et al
    COPS5 and LASP1 Synergistically Interact to Down-regulate 14-3-3sigma Expression and Promote Colorectal Cancer Progression via Activating PI3K/AKT Pathway.
    Int J Cancer. 2017 Dec 11. doi: 10.1002/ijc.31206.
    PubMed     Text format     Abstract available


  128. SCHWINGSHACKL L, Schwedhelm C, Hoffmann G, Knuppel S, et al
    Food groups and risk of colorectal cancer.
    Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31198.
    PubMed     Text format     Abstract available


  129. RAY AL, Berggren KL, Restrepo Cruz S, Gan GN, et al
    Inhibition of MK2 suppresses IL-1beta, IL-6, and TNF-alpha dependent colorectal cancer growth.
    Int J Cancer. 2017 Dec 2. doi: 10.1002/ijc.31191.
    PubMed     Text format     Abstract available


    November 2017
  130. BABAEI M, Balavarca Y, Jansen L, Lemmens V, et al
    Administration of Adjuvant Chemotherapy for Stage II-III Colon Cancer Patients: A European Population-based Study.
    Int J Cancer. 2017 Nov 21. doi: 10.1002/ijc.31168.
    PubMed     Text format     Abstract available


  131. YAMAUCHI M, Urabe Y, Ono A, Miki D, et al
    Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients.
    Int J Cancer. 2017 Nov 14. doi: 10.1002/ijc.31154.
    PubMed     Text format     Abstract available


  132. DI J, Yang H, Jiang B, Wang Z, et al
    Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
    Int J Cancer. 2017 Nov 6. doi: 10.1002/ijc.31140.
    PubMed     Text format     Abstract available


    October 2017
  133. ZHANG QL, Zhao LG, Li HL, Gao J, et al
    The joint effects of major lifestyle factors on colorectal cancer risk among Chinese men: A prospective cohort study.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31126.
    PubMed     Text format     Abstract available


  134. HOLCH JW, Ricard I, Stintzing S, Fischer von Weikersthal L, et al
    Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31114.
    PubMed     Text format     Abstract available


  135. NIELL N, Larriba MJ, Ferrer-Mayorga G, Sanchez-Perez I, et al
    The human PKP2/Plakophilin-2 gene is induced by Wnt/beta-catenin in normal and colon cancer-associated fibroblasts.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31104.
    PubMed     Text format     Abstract available


  136. HIDAYAT K, Yang CM, Shi BM
    Body Fatness at an Early Age and Risk of Colorectal Cancer.
    Int J Cancer. 2017 Oct 12. doi: 10.1002/ijc.31100.
    PubMed     Text format     Abstract available


  137. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    PubMed     Text format     Abstract available


  138. VARGAS-PARRA GM, Gonzalez-Acosta M, Thompson BA, Gomez C, et al
    Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Int J Cancer. 2017;141:1365-1380.
    PubMed     Text format     Abstract available


    September 2017
  139. TANSKANEN T, van den Berg L, Valimaki N, Aavikko M, et al
    Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.
    Int J Cancer. 2017 Sep 28. doi: 10.1002/ijc.31076.
    PubMed     Text format     Abstract available


  140. POTHOULAKIS C, Torre-Rojas M, Duran-Padilla MA, Gevorkian J, et al
    CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
    Int J Cancer. 2017 Sep 20. doi: 10.1002/ijc.31064.
    PubMed     Text format     Abstract available


  141. WANG W, Xiao X, Chen X, Huo Y, et al
    Tumor-suppressive miR-145 co-repressed by TCF4-beta-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31056.
    PubMed     Text format     Abstract available


  142. JAYASEKARA H, English DR, Haydon A, Hodge AM, et al
    Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31049.
    PubMed     Text format     Abstract available


  143. MA B, Gao P, Wang H, Xu Q, et al
    What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long-term outcomes over the past decades? A systematic review and meta-analysis based on 41,121 patients.
    Int J Cancer. 2017;141:1052-1065.
    PubMed     Text format     Abstract available


  144. VEDELD HM, Merok M, Jeanmougin M, Danielsen SA, et al
    CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
    Int J Cancer. 2017;141:967-976.
    PubMed     Text format     Abstract available


    July 2017
  145. SCHIRRIPA M, Zhang W, Heinemann V, Cao S, et al
    Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.
    Int J Cancer. 2017;141:383-392.
    PubMed     Text format     Abstract available


  146. GU F, Zhang H, Hyland PL, Berndt S, et al
    Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30883.
    PubMed     Text format     Abstract available


  147. CABEL L, Bidard FC, Servois V, Cacheux W, et al
    HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30863.
    PubMed     Text format     Abstract available


    June 2017
  148. VAN SEBILLE YZA, Gibson RJ, Wardill HR, Secombe KR, et al
    Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats.
    Int J Cancer. 2017;140:2820-2829.
    PubMed     Text format     Abstract available


    April 2017
  149. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: